As Moderna maps out a more cautious future amid lower-than-expected sales of its current products, the company is bolstering ...
Potenziare l’Arpa Sicilia attraverso nuove risorse umane ed economiche, con un finanziamento di due milioni di euro, nelle aree maggiormente critiche. “Per i prossimi tre anni l’Agenzia ...
Moderna (NASDAQ:MRNA) was among the notable gainers on Wednesday after Oracle (NYSE:ORCL) Chairman Larry Ellison highlighted the AI's potential in the development of messenger RNA-based cancer ...
Biotechnology company Moderna (NASDAQ:MRNA) gained the spotlight in the medical sector as a leader in the race toward a COVID-19 vaccine. Its messenger RNA (mRNA) technology garnered acclaim as a ...
Erica Denhoff / Icon Sportswire via Getty Images Moderna received a $590 million award from the U.S. government to speed development of a vaccine that could be used to fight bird flu. The biotech ...
TUESDAY, Jan. 21, 2025 (HealthDay News) -- The U.S. Department of Health and Human Services (HHS) is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to ...
Pharmaceutical company Moderna has been granted the funds to work on developing mRNA-based influenza vaccines, including for the strain causing the bird flu outbreak. Newsweek has contacted ...
↘️ MicroStrategy (MSTR): Cryptocurrencies pulled back after President Trump didn't mention crypto in his inauguration address. Shares in MicroStrategy, which also disclosed it had recently ...
Moderna Receives $590M From HHS to Develop Bird Flu Vaccine By India Edwards HealthDay Reporter TUESDAY, Jan. 21, 2025 (HealthDay News) -- The U.S. Department of Health and Human Services (HHS) is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results